Business Context and Reporting Period
Company: Veeco Instruments Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2001
Business Overview: Veeco designs, manufactures, and markets process equipment and metrology systems for the data storage, semiconductor, and optical/wireless telecommunications industries. The company operates through three primary segments: Process Equipment, Metrology, and Industrial Measurement.
Key Financial Metrics
| Metric (in thousands) | Three Months Ended Sep 30, 2001 | Nine Months Ended Sep 30, 2001 |
|---|---|---|
| Net Sales | $115,951 | $356,674 |
| Gross Profit | $50,836 | $163,624 |
| Gross Margin | 43.8% | 45.9% |
| Operating Income | $4,070 | $37,814 |
| Net Income | $1,848 | $24,721 |
| Diluted EPS | $0.07 | $0.97 |
| Cash from Operations (9mo) | $13,428 | |
| Cash & Equivalents (Sep 30, 2001) | $55,160 | |
| Long-Term Debt (Sep 30, 2001) | $38,055 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 43% ($34.9M) for the quarter and 32% ($86.4M) for the nine months compared to 2000. Growth was driven by Process Equipment (up 70% QoQ) and Metrology (up 22% QoQ).
- Profitability Decline: Despite revenue growth, Net Income for the quarter dropped 42% to $1.8M from $3.2M in the prior year. This was primarily due to an $8.2M non-recurring write-off of purchased in-process technology related to recent acquisitions.
- Order Backlog: New orders decreased significantly. For the quarter, orders fell 65% to $62.6M, resulting in a book-to-bill ratio of 0.54. For the nine months, orders fell 39% to $256.9M (book-to-bill 0.72).
- Acquisitions: The company completed the acquisition of Applied Epi, Inc. (molecular beam epitaxy equipment) and ThermoMicroscopes Corp. (atomic force microscopes) in 2001, significantly increasing intangible assets and goodwill.
Guidance, Outlook, and Risks
- Cost Reduction Plan: Due to a weakening business environment, management plans to implement a cost reduction program in Q4 2001, including a workforce reduction of approximately 15% and plant consolidations. A restructuring charge of $15.0M to $20.0M is expected in Q4.
- Order Cancellations: The company experienced order cancellations representing 26% of the Q2 backlog, primarily in the optical telecommunications sector. Rescheduling of delivery dates is also occurring.
- Liquidity: The company maintains a $100M revolving credit facility with $25M outstanding as of September 30, 2001. Management believes existing cash and credit facilities are sufficient for the next 12 months.
- Legal Proceedings: Toyo Corporation has sued Veeco and its subsidiary ThermoMicroscopes regarding a distribution agreement in Japan. Veeco intends to defend vigorously and does not expect a material financial impact.
- Accounting Changes: The adoption of SFAS 142 (Goodwill) will eliminate amortization of goodwill starting in 2002, expected to reduce expenses by approximately $1.6M annually.
Investor Verification Checklist
- Order Trends: Verify the sustainability of the 65% drop in quarterly orders and the impact of the 0.54 book-to-bill ratio on future revenue guidance.
- Restructuring Costs: Monitor the Q4 2001 financials for the anticipated $15M-$20M restructuring charge and its effect on full-year profitability.
- Acquisition Integration: Assess the performance of Applied Epi and ThermoMicroscopes post-acquisition, specifically regarding the $8.2M write-off of in-process technology.
- Telecom Exposure: Evaluate the company's exposure to the optical telecommunications market, which has driven recent order cancellations and rescheduling.
- Working Capital: Review the $30.4M increase in inventory levels to ensure it aligns with rescheduled shipments rather than obsolescence risks.